G. Cohen

Laser treatment in eyes with large drusen. Short-term effects seen in a pilot randomized clinical trial. Choroidal Neovascularization Prevention Trial Research Group.

Mark S. Blumenkranz, David F. Wilson, T. A. Rice, 1998, Ophthalmology.

Ursodeoxycholic Acid and F6-D3 Inhibit Aberrant Crypt Proliferation in the Rat Azoxymethane Model of Colon Cancer

M. Bissonnette, M. Tretiakova, R. Wali, 2002 .

Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin.

M. Bissonnette, M. Tretiakova, R. Wali, 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Protein kinase C delta inhibits Caco-2 cell proliferation by selective changes in cell cycle and cell death regulators

P. Majumder, M. Bissonnette, S. Cerda, 2006, Oncogene.

Ursodeoxycholic acid inhibits Ras mutations, wild-type Ras activation, and cyclooxygenase-2 expression in colon cancer.

M. Bissonnette, M. Tretiakova, G. Boss, 2003, Cancer research.

Gene Signature Distinguishes Patients with Chronic Ulcerative Colitis Harboring Remote Neoplastic Lesions

M. Westerhoff, S. Levy, M. Bissonnette, 2013, Inflammatory bowel diseases.

Ursodeoxycholic Acid Suppresses Cox-2 Expression in Colon Cancer: Roles of Ras, p38, and CCAAT/Enhancer-Binding Protein

M. Bissonnette, M. Tretiakova, A. Fichera, 2008, Nutrition and cancer.

Epidermal growth factor receptor signaling is up-regulated in human colonic aberrant crypt foci.

M. Bissonnette, M. Tretiakova, A. Fichera, 2006, Cancer research.

Epidermal growth factor receptor signaling is required for microadenoma formation in the mouse azoxymethane model of colonic carcinogenesis.

M. Bissonnette, M. Tretiakova, A. Fichera, 2007, Cancer research.